Acurian Delivers 22% of Randomized Patients for a Phase II Trial of Patients with Diabetic Foot Ulcers


Diabetic Foot Ulcers

In order to begin phase III trials, a sponsor needed to complete the phase II study of its intramuscular injection therapy for patients who had diabetic foot ulcers with and without peripheral  arterial disease. The plan was to randomize 133 dosed patients over an enrollment period of 26 months.

Read More »